"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
| Descriptor ID |
D013759
|
| MeSH Number(s) |
D02.455.849.090.810
|
| Concept/Terms |
Dronabinol- Dronabinol
- delta(9)-THC
- 9-ene-Tetrahydrocannabinol
- 9 ene Tetrahydrocannabinol
- THC
- delta(1)-Tetrahydrocannabinol
- delta(1)-THC
- delta(9)-Tetrahydrocannabinol
- Tetrahydrocannabinol
|
Below are MeSH descriptors whose meaning is more general than "Dronabinol".
Below are MeSH descriptors whose meaning is more specific than "Dronabinol".
This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 0 | 2 |
| 2007 | 3 | 0 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dronabinol" by people in Profiles.
-
Raghunathan NJ, Brens J, Vemuri S, Li QS, Mao JJ, Korenstein D. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center. Support Care Cancer. 2022 Sep; 30(9):7491-7497.
-
Boyer EW, Levy S, Smelson D, Vargas S, Casey A. The Clinical Assessment of Vaping Exposure. J Addict Med. 2020 12; 14(6):446-450.
-
Burstein S. Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum. Mol Pharmacol. 2021 02; 99(2):125-132.
-
Blohm E, Sell P, Neavyn M. Cannabinoid toxicity in pediatrics. Curr Opin Pediatr. 2019 04; 31(2):256-261.
-
Burstein SH. Ajulemic acid: potential treatment for chronic inflammation. Pharmacol Res Perspect. 2018 04; 6(2):e00394.
-
Fantasia HC. Pharmacologic Implications of Marijuana Use During Pregnancy. Nurs Womens Health. 2017 Jun - Jul; 21(3):217-223.
-
Bluett RJ, B?ldi R, Haymer A, Gaulden AD, Hartley ND, Parrish WP, Baechle J, Marcus DJ, Mardam-Bey R, Shonesy BC, Uddin MJ, Marnett LJ, Mackie K, Colbran RJ, Winder DG, Patel S. Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nat Commun. 2017 03 28; 8:14782.
-
Neavyn MJ, Blohm E, Babu KM, Bird SB. Medical marijuana and driving: a review. J Med Toxicol. 2014 Sep; 10(3):269-79.
-
Tepper MA, Zurier RB, Burstein SH. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Bioorg Med Chem. 2014 Jul 01; 22(13):3245-51.
-
Burstein SH. The cannabinoid acids, analogs and endogenous counterparts. Bioorg Med Chem. 2014 May 15; 22(10):2830-43.